课题基金 / 基金详情

IGF::OT::IGF SMARTT BIOLOGICS PRODUCTION FACILITY (PF); BASE PERIOD; FY16; AMT $2,069,079; CAN 8470205

IGF::OT::IGF SMARTT BIOLOGICS PRODUCTION FACILITY (PF); BASE PERIOD; FY16; AMT $2,069,079; CAN 8470205
IGF::OT::IGF SMARTT 生物制品生产设施 (PF)；
批准号：
10895248
负责人：
PHILLIP ISHIKAWA
金额：
$16.28万
依托单位：
ADVANCED BIOSCIENCE LABORATORIES, INC.
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
项目状态：
已结题
起止时间：
2016-03-01 至 2019-02-07
来源：
https://reporter.nih.gov/project-details/10895248
关键词：
AddressBiological ProductsCollaborationsCommunicationDiseaseEducationFamilyFosteringGovernment AgenciesHealthHealth ProfessionalHeart DiseasesHematological DiseaseIndividualIndustryInstitutionInternationalLeadershipLung diseasesMentorsNational Heart, Lung, and Blood InstitutePatientsPhysiciansPreventionPrivatizationProductionProfessional OrganizationsPublic HealthResearchResearch InfrastructureResourcesScientistTrainingTranslationsbaseclinical practicecommunity organizationspatient advocacy groupprograms

项目摘要

项目成果

PHILLIP ISHIKAWA的其他基金

相似基金

相关文献

中文摘要
翻译
国家心脏，肺和血液研究所（NHLBI）为研究，培训和教育计划提供全球领导，以促进心脏，肺和血液疾病的预防和治疗，并增强所有人的健康，使他们能够活得更长，更充实的生活。
英文摘要
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PRECLINICAL SERVICES FOR BIOPHARMACEUTICAL PRODUCT DEVELOPMENT
NIAID PRECLINICAL DEVELOPMENT SUPPORT - SUPPORT FOR PRODUCTION AND TESTING OF ADC6-HIV GP140 AND ADC7-HIV GP140
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - SUPPORT FOR PRODUCTION AND TESTING OF ADC6-HIV GP140 AND ADC7-HIV GP140
NIAID PRECLINICAL DEVELOPMENT SUPPORT - SUPPORT FOR PRODUCTION AND TESTING OF ADC6-HIV GP140 AND ADC7-HIV GP140
海外基金